Year: 2025

MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD), announced the addition of 85 cardiovascular centers and data sources, expanding its Cardiovascular network thereby positioning OneMedNet as one of the largest providers for Cardiovascular Real-World data. Cardiovascular diseases (CVDs) remain the world’s leading cause of death, responsible for approximately 19.8 million deaths in 2022, accounting for roughly 32% of all global mortality1. Economically, the burden is staggering: CVD drives an estimated $320 billion annually in the United States alone, and more than $1 trillion globally each year in direct healthcare costs and lost productivity2. Such pervasive health and financial pressures make OneMedNet’s enriched multimodal...

Hotel101-Phnom Penh Cambodia is set to have approx 700 rooms with 30 floors to rise in a prime 2,033 square meters commercial land at Tonle Bassac, a vibrant riverfront economic and cultural hub near the popular upscale BKK District Hotel101-Sihanoukville Cambodia is set to have approx 680 rooms to rise in a prime 4,623 square meters commercial land right beside the proposed international convention and exhibition center within the master-planned Bay of Lights coastal development Hotel101-Phnom Penh and Hotel101-Sihanoukville projects in Cambodia are expected to generate $109.55 Million USD in sales revenue Hotel101’s entry to the Cambodian market to add to the current hospitality offerings that are now already operating in Cambodia which includes global hotel brands such as Hyatt, Rosewood, Raffles and Shangri-La Cambodia is seen...

Today, Landsbankinn concluded the sale of floating rate senior preferred bonds in the amount of NOK 400 million with a maturity of three years. The bonds were priced at a spread of 87bps over 3-month NIBOR. The bonds will be issued under the bank’s EMTN programme and expected to be admitted to trading on Euronext Dublin as of 28 August 2025. SEB acted as a dealer on the transaction.

Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline Confirmed significant biomarker-response in hippocampus NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today reported a peer-reviewed publication in the journal Neuroscience Letters, titled “Prevention of memory impairment and hippocampal injury with blarcamesine in an Alzheimer’s disease model.”1 This study shows that a pre-treatment with blarcamesine prevented Amyloid beta-induced memory impairment...

The Investment is part of BrainsWay’s ongoing strategy to acquire minority positions in leading U.S. mental health providers to help them raise awareness for and expand access to transformative care BURLINGTON, Mass. and JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has entered into a strategic equity financing agreement with Axis Management Company, Inc. (“Axis Integrated Mental Health” or “Axis”), a management services organization servicing several mental health clinics in Colorado. Under the terms of the agreement, BrainsWay will invest $2.3 million initially, and an additional potential $1 million milestone-based investment, for a minority...

BEIJING, Aug. 20, 2025 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced the upsizing and extension of its share repurchase program. As previously announced, the Company established a share repurchase program on August 29, 2024, whereby the Company was authorized to repurchase up to US$150 million of its shares (including in the form of American depositary shares (“ADS”)) for a 12-month period. On August 20, 2025, the Company’s board of directors approved amendments to its existing share repurchase program, extending the program for a 12-month period through August 28, 2026 and authorizing repurchases of up to US$250 million of the Company’s shares (including ADSs) during the extended 12-month period. Safe Harbor Statement This...

BEIJING, Aug. 20, 2025 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that Ms. Mengyuan Dong has resigned as an independent non-executive director of the Company in order to devote more time to her other personal business commitments, effective on August 20, 2025. In addition, with effect from August 20, 2025, Ms. Hongyu Liu, an independent non-executive director and a member of the nomination committee has been appointed as the chairman of the audit committee and a member of the corporate governance committee. Mr. Yan Li, an independent non-executive director, the chairman of the nomination committee, the chairman of the corporate governance committee, and a member of the audit committee, has been appointed as a member...